However, recent research has shed light on the role of serum Lp(a) as an independent causal risk factor in the development of CAVD, highlighting its significance in the pathogenesis and progression of this common heart valve disorder [5,130]. This evidence concerns the gene LPA and congenital bilateral aplasia of vas deferens from CFTR mutation.